GSK-LSD1是一种具有选择性的 LSD1 抑制剂,具有潜在的抗癌活性,可在癌细胞中减弱 CTGF/CCN2、MMP13、LOXL4 和波形蛋白的表达。GSK-LSD1 可调节细胞周期,诱导细胞凋亡,可用于研究乳腺癌。 规格价格库存数量 1 mg¥ 198现货 5 mg¥ 457现货 10 mg¥ 659现货 ...
生物活性体外研究GSK-LSD1 试剂级价格 GSK-LSD1 CAS号: 1431368-48-7 英文名: GSK-LSD1 英文别名: GSK-LSD1 2HCl;CS-1628;GSK-LSD;GSK-LSD1;GSK-LSD1 HC'k;GSKLSD1 GSK LSD1;GSK-LSD1(LSD1inhibitor);GSK-LSD1 2hydrochloride;GSK-LSD1 2HCl USP/EP/BP;GSK-LSD1 (trans-racemic) ...
GSK-LSD1,LSD1Inhibitor的详细介绍 Product Information Molecular Weight:289.24 Formula:C14H22Cl2N2 Purity:≥98% CAS#:1431368-48-7 Solubility:DMSO up to 100 mM Chemical Name:N-((1R,2S)-2-phenylcyclopropyl)piperidin-4-amine HCl salt Storage:Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC ...
GSK-LSD1二盐酸盐用途 GSK-LSD1 is a potent and selective inhibitor of lysine specific demethylase 1 (LSD1). GSK-LSD1 potently inhibits proliferation of varies cancer cell lines by changing gene expression patterns. GSK-LSD1 inhibits LSD1 with an IC50 of 16 nM and is > 1000 fold selective...
GSK-LSD1,an LSD1 inhibitor,quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro drugsmortalitycytokineDear Editor,Since the COVID-19 demonstrated a remarkable transmission speed and a high mortality risk,COVID-19 is currently declared as a pandemic by the World Health Organization.This ...
An LSD1 inhibitor 此产品仅用于科学研究,我们不为任何个人用途提供产品和服务 库存:现货 可选规格 包装 5mg 10mg 25mg 50mg 数量 确认取消 ￥690-3590 包装 价格 促销价 数量 5mg ￥862.00 690.00 -+ 10mg ￥1287.00 1030.00 -+ 25mg ￥2587.00
An LSD1 inhibitor 此产品仅用于科学研究,我们不为任何个人用途提供产品和服务 库存:现货 可选规格 包装 5mg 25mg 数量 确认取消 ￥640-2370 包装 价格 促销价 数量 5mg ￥800.00 640.00 -+ 25mg ￥2962.00 2370.00 -+ 已选0种0瓶 金额:￥0.00
1mL(10mM)|2mg|5mg|10mg|50mg|100mg发货周期:1～3天产品价格:询价本产品仅可用于科研实验,严禁用于其他非科研用途!GSK2879552是一种不可逆的LSD1抑制剂,具有抗肿瘤活性。注:本品仅可用于科研实验,严禁用于临床医疗及其他用途!CAS号:1401966-69-5纯度:99.82%分子式:C23H28N2O2分子量:364.48结构式:储存条件:-...
an inhibitor of PKCα that phosphorylates LSD1, and GSK-LSD1, which directly inhibits activation of LSD1, could improve survival rate in the septic mouse model by inhibiting the PKCα-LSD1-NF-κB pathway.3In this regard, we treated the PBMCs isolated from severe COVID-19 patients with Go...
Supplementary Methods, Tables 1–17, Figs. 1–14 and references. Reporting Summary About this article Cite this article Schober, M., MacDermaid, C., Ollis, A.A.et al.Chiral synthesis of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine reductase.Nat Catal2, 909–915 (20...